MEGAN MCCALL: Open Payments
NPI 1134524929 · HARRISVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 39 payments from 8 companies in 2025. Trend: 2023 $795 · 2024 $1,413 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $295 |
| ABBVIE INC. | 12 | $194 |
| Lilly USA, LLC | 5 | $97 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Kowa Pharmaceuticals America, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: Ozempic, UBRELVY, MOUNJARO, QULIPTA, Wegovy, Rybelsus, ZORYVE, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
